ArticleJournal of hepatocellular carcinoma2026
Association of week-2 Contrast-Enhanced Ultrasound Perfusion Changes with Response to Lenvatinib Plus PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study.
Hang Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.